TY - JOUR
T1 - The effect of exposure to radiofrequency fields on cancer risk in the general and working population
T2 - A protocol for a systematic review of human observational studies
AU - Lagorio, Susanna
AU - Blettner, Maria
AU - Baaken, Dan
AU - Feychting, Maria
AU - Karipidis, Ken
AU - Loney, Tom
AU - Orsini, Nicola
AU - Röösli, Martin
AU - Paulo, Marilia Silva
AU - Elwood, Mark
N1 - Funding Information:
This project is supported by the World Health Organization (grant numbers: RAD 2020/1031788–0; RAD 2020/994756–0). Co-financing was provided by the New Zealand Ministry of Health; the Istituto Superiore di Sanità in its capacity as a WHO Collaborating Centre for Radiation and Health; ARPANSA as a WHO Collaborating Centre for Radiation Protection.
Funding Information:
Susanna Lagorio was principal investigator (April 2019 – March 2020) of the research project “BRiC 2018/06 - Systematic reviews of exposure to radiofrequency fields and cancer”, supported by the Italian Workers’ Compensation Authority, a public no-profit entity (grant code I85B19000120005). Her employment duties involve provision of advice on health hazards from exposure to RF-EMF to the Italian Ministry of Health and Higher Health Council.
Publisher Copyright:
© 2021 The Authors
PY - 2021/12
Y1 - 2021/12
N2 - Background: The World Health Organization (WHO) has an ongoing project to assess potential health effects of exposure to radiofrequency electromagnetic fields (RF-EMF) in the general and working population. Here we present the protocol for a systematic review of the scientific literature on cancer hazards from exposure to RF-EMF in humans, commissioned by the WHO as part of that project. Objective: To assess the quality and strength of the evidence provided by human observational studies for a causal association between exposure to RF-EMF and risk of neoplastic diseases. Eligibility criteria: We will include cohort and case-control studies investigating neoplasia risks in relation to three types of exposure to RF-EMF: near-field, head-localized, exposure from wireless phone use (SR-A); far-field, whole body, environmental exposure from fixed-site transmitters (SR-B); near/far-field occupational exposures from use of handheld transceivers or RF-emitting equipment in the workplace (SR-C). While no restriction on tumour type will be applied, we will focus on selected neoplasms of the central nervous system (brain, meninges, pituitary gland, acoustic nerve) and salivary gland tumours (SR-A); brain tumours and leukaemias (SR-B, SR-C). Information sources: Eligible studies will be identified through Medline, Embase, and EMF-Portal. Risk-of-bias assessment: We will use a tailored version of the OHAT's tool to evaluate the study's internal validity. Data synthesis: We will consider separately studies on different tumours, neoplasm-specific risks from different exposure sources, and a given exposure-outcome pair in adults and children. When a quantitative synthesis of findings can be envisaged, the main aims of the meta-analysis will be to assess the strength of association and the shape of the exposure–response relationship; to quantify the degree of heterogeneity across studies; and explore the sources of inconsistency (if any). When a meta-analysis is judged inappropriate, we will perform a narrative synthesis, complemented by a structured tabulation of results and appropriate visual displays. Evidence assessment: Confidence in evidence will be assessed in line with the GRADE approach. Funding: This project is supported by the World Health Organization. Co-financing was provided by the New Zealand Ministry of Health; the Istituto Superiore di Sanità in its capacity as a WHO Collaborating Centre for Radiation and Health; ARPANSA as a WHO Collaborating Centre for Radiation Protection. Registration: PROSPERO CRD42021236798.
AB - Background: The World Health Organization (WHO) has an ongoing project to assess potential health effects of exposure to radiofrequency electromagnetic fields (RF-EMF) in the general and working population. Here we present the protocol for a systematic review of the scientific literature on cancer hazards from exposure to RF-EMF in humans, commissioned by the WHO as part of that project. Objective: To assess the quality and strength of the evidence provided by human observational studies for a causal association between exposure to RF-EMF and risk of neoplastic diseases. Eligibility criteria: We will include cohort and case-control studies investigating neoplasia risks in relation to three types of exposure to RF-EMF: near-field, head-localized, exposure from wireless phone use (SR-A); far-field, whole body, environmental exposure from fixed-site transmitters (SR-B); near/far-field occupational exposures from use of handheld transceivers or RF-emitting equipment in the workplace (SR-C). While no restriction on tumour type will be applied, we will focus on selected neoplasms of the central nervous system (brain, meninges, pituitary gland, acoustic nerve) and salivary gland tumours (SR-A); brain tumours and leukaemias (SR-B, SR-C). Information sources: Eligible studies will be identified through Medline, Embase, and EMF-Portal. Risk-of-bias assessment: We will use a tailored version of the OHAT's tool to evaluate the study's internal validity. Data synthesis: We will consider separately studies on different tumours, neoplasm-specific risks from different exposure sources, and a given exposure-outcome pair in adults and children. When a quantitative synthesis of findings can be envisaged, the main aims of the meta-analysis will be to assess the strength of association and the shape of the exposure–response relationship; to quantify the degree of heterogeneity across studies; and explore the sources of inconsistency (if any). When a meta-analysis is judged inappropriate, we will perform a narrative synthesis, complemented by a structured tabulation of results and appropriate visual displays. Evidence assessment: Confidence in evidence will be assessed in line with the GRADE approach. Funding: This project is supported by the World Health Organization. Co-financing was provided by the New Zealand Ministry of Health; the Istituto Superiore di Sanità in its capacity as a WHO Collaborating Centre for Radiation and Health; ARPANSA as a WHO Collaborating Centre for Radiation Protection. Registration: PROSPERO CRD42021236798.
KW - Acoustic neuroma
KW - Base stations
KW - Brain cancer
KW - Broadcast transmitters
KW - Case-control studies
KW - Childhood leukaemia
KW - Cohort studies
KW - Cordless phones
KW - Epidemiology
KW - Glioma
KW - Leukaemia
KW - Meningioma
KW - Microwaves
KW - Mobile phones
KW - Neoplasms
KW - Occupational exposure
KW - Pituitary tumours
KW - Radiofrequency electromagnetic fields
KW - Salivary gland tumours
KW - Systematic review protocol
UR - http://www.scopus.com/inward/record.url?scp=85113617578&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85113617578&partnerID=8YFLogxK
U2 - 10.1016/j.envint.2021.106828
DO - 10.1016/j.envint.2021.106828
M3 - Article
C2 - 34433115
AN - SCOPUS:85113617578
SN - 0160-4120
VL - 157
JO - Environmental International
JF - Environmental International
M1 - 106828
ER -